About this collection

Recent Submissions

  • ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia. 

    Pritchard, Natasha; Kaitu'u-Lino, Tu'uhevaha J; Gong, Sung Sam; Dopierala, Justyna; Smith, Gordon Campbell; Charnock-Jones, David Stephen; Tong, Stephen (American Society for Investigative Pathology, 2018-08)
    The genetic deletion of Elabela (encoding the peptide hormone Apelin Receptor Early Endogenous Ligand) produces a preeclampsia-like phenotype in mice. However, evidence linking ELABELA with human disease is lacking. ...
  • Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study. 

    Gaccioli, Francesca; Sovio, Ulla Maarit; Cook, Emma; Hund, Martin; Charnock-Jones, David Stephen; Smith, Gordon Campbell (Elsevier, 2018-08)
    ABSTRACT Background Fetal growth restriction is a major determinant of perinatal morbidity and mortality. The condition has no gold standard definition but a widely used proxy is delivery of a small for gestational age ...
  • Correcting for optimistic prediction in small data sets. 

    Smith, Gordon Campbell; Seaman, Shaun; Wood, Angela Mary; Royston, Patrick; White, Ian R (2014-08)
    The C statistic is a commonly reported measure of screening test performance. Optimistic estimation of the C statistic is a frequent problem because of overfitting of statistical models in small data sets, and methods exist ...
  • Universal screening for foetal growth restriction. 

    Smith, Gordon Campbell (Elsevier, 2018-05)
    Fetal growth restriction (FGR) is a major cause of morbidity and mortality. Clinical methods for identifying women whose pregnancies are affected by FGR do not perform well. Despite this, the current approach to screening ...

View more